
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May ...

Emerald receives certain exclusive rights to established Phytosome® technology to enhance absorption and bioavailability ...

-- U.S. Food and Drug Administration (FDA) Agreed that Bardet-Biedl Syndrome (BBS) and Alström ...
Click to continue to site. Closing